21 May 2013
3 February 1992
A new review of the drug products which are to remain under government price control is reportedly causing delay in...
3 February 1992
A bill allowing the establishment of a private health care sector in Mozambique for the first time since 1975 is...
3 February 1992
Hoechst Celanese Corp, a US subsidiary of Hoechst-AG, one of the companies behind the manufacturers of the controversial abortifacient drug...
3 February 1992
Diabetes researchers at the University of Texas Southwestern Medical Center, Dallas, USA, have taken a first step towards the creation...
3 February 1992
Enzon has signed an agreement with Allelix Biopharmaceuticals for the development of a modified version of epidermal growth factor, using...
3 February 1992
Ciba-Geigy's intention to move decisively to take advantage of current expansion of the self-medication market is reflected in its active...
3 February 1992
- SmithKline Beecham has received approval from the US Food and Drug Administration to market Triostat (tri-iodothyronine) its orphan drug...
3 February 1992
- Swiss pharmaceutical concern Solco's immunomodulator product SolcoUrovac has been found to be 71% effective in preventing recurrent urinary tract...
3 February 1992
- Robin Burrows has resigned as vice president of corporate development with Forest Labor-atories Inc, and is presently acting as...
3 February 1992
- Antolin Rodriguez Martinez has been appointed as director of Spain's national institute for health, Insalud.